Patent details

EP2496580 Title: BENZODIAZEPINE BROMODOMAIN INHIBITOR

Basic Information

Publication number:
EP2496580
PCT Application Number:
PCT/EP/2010/061518
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107406548
PCT Publication Number:
WO/2011/054553
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BENZODIAZEPINE BROMODOMAIN INHIBITOR
French Title of Invention:
INHIBITEUR DE BROMODOMAINE DE BENZODIAZÉPINE
German Title of Invention:
BENZODIAZEPIN-BROMDÖMÄNENHEMMER
SPC Number:

Dates

Filing date:
06/08/2010
Grant date:
11/12/2013
EP Publication Date:
11/12/2013
PCT Publication Date:
12/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2012
EP B1 Publication Date:
11/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/08/2021
Expiration date:
06/08/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/01/2018
 
 

Name:
GlaxoSmithKline LLC
Address:
251 Little Falls Drive, Wilmington, DE 19808, United States (US)

History of Owners

From:
19/12/2013
To:
10/01/2018

Name:
GlaxoSmithKline LLC
Address:
Corporation Service Company 2711 Centreville Road Suite 40, Wilmington, Delaware 19808, United States (US)

Agent

Name:
KIRKPATRICK SA / NV
From:
17/02/2014
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
GOSMINI Romain Luc Marie
Address:
France (FR)

2

Name:
MIRGUET Olivier
Address:
France (FR)

Priority

1

Priority Number:
0919433
Priority Date:
05/11/2009
Priority Country:
United Kingdom (GB)

2

Priority Number:
201010509
Priority Date:
22/06/2010
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 487/04;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/03
Publication date:
20/02/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20180000011A
Date Registered:
10/01/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changements de noms et d'adresses
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GlaxoSmithKline LLC
Address:
251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
15/07/2020
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
10/01/2018 Request For Change 4
11/01/2018 Outgoing Correspondence 1